HMGA2 and hepatocellular carcinoma: It has been detected to have higher expression in hepatocellular carcinoma (HCC), associated with worse clinical outcomes, and functions as an oncogene by interacting with the transcription factor HMGA2 to activate the Wnt/β-catenin signaling pathway in hepatocellular carcinoma [38].